Bristol Myers Squibb shares rise post-summit due to policy optimism

Senators Marshall and Welch's presence at the summit suggests bipartisan healthcare policy momentum. Bristol Myers Squibb, a major pharma player, is likely to benefit from potential regulatory clarity or funding announcements.

Implied probability (Yes)

70%